Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Sep 12, 2024 9:03am
RE:RE:RE:RE:RE:RE:RE:RE:Andrey Omelchak - BNN - TOP PICK
I agree that the share price has worked out well for the company in terms of issuing and buying back shares, but in theory the company is very undervalued today, Goodman could buy the company for
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Sep 12, 2024 2:39am
RE:RE:RE:RE:RE:RE:RE:Andrey Omelchak - BNN - TOP PICK
I don't even know why Goodman would want to take GUD private. I doubt he's disappointed or frustrated about the share price; on the contrary, the company takes an advantage of that. The share
...more
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m
posted Nov 13, 2024 9:00am by
Freegold Ventures Limited
-
|
Four specific holes were drilled to facilitate additional metallurgical testing and were strategically designed to collect representative material from the deposit while improving infill drilling efforts. Approximately ~2,400 meters of ½ PQ core (~ 20 tonnes) have been shipped to BaseMet Labs in Kamloops, BC, where a comprehensive suite of metallurgical testing is currently underway ...read more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Sep 12, 2024 2:27am
RE:RE:Andrey Omelchak - LionGuard Capital Management GUD Letter
Yes -- going private would be out of character for Goodman. While the stock price has lagged behind for a long time, the market has still been plenty useful for Knight. Knight went to the market to
...more
(152)
•••
longrun86
X
View Profile
View Bullboard History
Comment by
longrun86
on Sep 11, 2024 7:21pm
RE:Andrey Omelchak - LionGuard Capital Management GUD Letter
I would be very surprised for this to go private based on Goodman's comments when it was established 10 years ago. The core group of investors who have invested with him since Knight was
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Post by
EbbFlow88
on Sep 11, 2024 3:50pm
Andrey Omelchak - LionGuard Capital Management GUD Letter
Knight Therapeutics (GUD) stands out as a true hidden gem, not only for its excellent free cash flow generation, huge net cash position, and solid growth rate but also for the strategic acumen of its
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Sep 11, 2024 3:45pm
RE:RE:RE:RE:RE:RE:Andrey Omelchak - BNN - TOP PICK
I also think that Goodman has other concerns other than maximizing return for himself. Although he made a lot of money from Paladin, it doesn't seem that it was the way he wanted to go out
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Sep 11, 2024 3:10pm
RE:RE:RE:RE:RE:Andrey Omelchak - BNN - TOP PICK
I think Goodman would have a lot of influence in an acquisition type of situation even if he does not control the vote directly. Anything can happen though! But I do believe a low multiple bid is very
...more
(120)
•••
Catscratch
X
View Profile
View Bullboard History
Comment by
Catscratch
on Sep 11, 2024 12:36pm
RE:RE:RE:RE:Andrey Omelchak - BNN - TOP PICK
So many TSX SMID caps getting taken out at low valuations . Knight would be on the list for sure. Goodman owns 22% so I don't think really in a position to block an acquisition.&
...more
(1869)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Comment by
Possibleidiot01
on Sep 10, 2024 6:15pm
RE:RE:RE:Andrey Omelchak - BNN - TOP PICK
stockchase.com TOP PICK Knight Therapeutics(GUD-T) 10/09/2024 A hidden gem. Low liquidity, but has good topline growth, strong margin expansion
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Sep 10, 2024 4:17pm
RE:RE:Andrey Omelchak - BNN - TOP PICK
The video is here, by the way: https://www.bnnbloomberg.ca/video/shows/market-call/2024/09/10/andrey-omelchaks-top-pickslumine-trisura-group-and-knight-therapeutics/
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Sep 10, 2024 4:16pm
RE:Andrey Omelchak - BNN - TOP PICK
A successful investor once told me some stocks stay significantly undervalued for a long time, the market fails to recognize them for whatever reason... and eventually they just get acquired. I've
...more
(1869)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Sep 10, 2024 3:12pm
Andrey Omelchak - BNN - TOP PICK
Andrey Omelchak’s Top Picks for September 10, 2024 By BNNBloomberg.ca Staff September 10, 2024 at 1:38PM EDT Andrey Omelchak, president and CIO at
...more
(8)
•••
wofats
X
View Profile
View Bullboard History
Post by
wofats
on Sep 09, 2024 11:18am
From Simply Wall St
Knight Therapeutics (TSX:GUD) Simply Wall St Growth Rating: Overview: Knight Therapeutics Inc. develops, manufactures, acquires, licenses, markets, and distributes pharmaceutical and consumer
...more
(8)
•••
wofats
X
View Profile
View Bullboard History
Post by
wofats
on Sep 07, 2024 11:27am
Buy backs
Filed 2024-09-06 07:30 Tx date 2024-08-30 $GUD Knight Therapeutics Inc. Knight Therapeutics Inc. 1 - Issuer Direct Ownership
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet the Top 5 Best Online Brokerages in Canada
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips